Fact-checking stem cell therapy for autism: still a risky idea 
Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs 
Translating the FDA’s Q&A on end of stem cell grace period 
Stem cell therapy: the good, the bad, & the muddy waters 
Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs Fact-checking stem cell therapy for autism: still a risky idea
The other day I gave a talk in part about stem cell hype and mentioned…
Weekly reads: CRISPR’d marsupial, outpatient recovery post stem cell transplants, Parkinson’s, pubs
This edition of The Niche weekly reads has a bit more good news than usual…
Translating the FDA’s Q&A on end of stem cell grace period
The FDA grace period for stem cell clinics and others using regenerative medicine products like…
Stem cell therapy: the good, the bad, & the muddy waters
How can you tell who to trust in the world of stem cell therapy? What…
Weekly reads: stem cells to gametes, no PRP benefit, WHO CRISPR, pubs
The paper of the week is from Science on making ovarian follicles and actual eggs…
Enter The Niche stem cell videos contest with $100 prize
Who doesn’t like stem cell videos? Some of you already know that we have a…
Stem cell Alzheimer’s disease research
Could stem cell Alzheimer’s Disease (AD) research provide a potential path to future treatment or…
Weekly reads: stem cells vs. viruses, prostate cancer, apoptotic cell niche function, more
The paper of the week is An isoform of Dicer protects mammalian stem cells against…
FDA alleges Cell Surgical Network links to US Stem Cell & COVID plan
The FDA has sought injunctions in federal court against two stem cell clinic firms including…
How should we define a stem cell doctor?
Over the past half dozen or so years I’ve seen far more physicians describing themselves…